Arcus Biosciences Inc (RCUS)
15.37
-0.26
(-1.66%)
USD |
NYSE |
Apr 30, 12:49
Arcus Biosciences Cash from Operations (Quarterly): -88.00M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -88.00M |
| September 30, 2023 | -63.00M |
| June 30, 2023 | -57.00M |
| March 31, 2023 | -98.00M |
| December 31, 2022 | -70.00M |
| September 30, 2022 | -81.00M |
| June 30, 2022 | -65.00M |
| March 31, 2022 | 654.00M |
| December 31, 2021 | -61.93M |
| September 30, 2021 | -53.76M |
| June 30, 2021 | -74.00M |
| March 31, 2021 | -66.32M |
| December 31, 2020 | -50.05M |
| September 30, 2020 | 216.26M |
| Date | Value |
|---|---|
| June 30, 2020 | -23.94M |
| March 31, 2020 | -31.28M |
| December 31, 2019 | -9.471M |
| September 30, 2019 | -27.40M |
| June 30, 2019 | -19.75M |
| March 31, 2019 | -16.84M |
| December 31, 2018 | -7.107M |
| September 30, 2018 | -11.76M |
| June 30, 2018 | -10.88M |
| March 31, 2018 | -13.25M |
| December 31, 2017 | 15.59M |
| September 30, 2017 | -24.23M |
| June 30, 2017 | -6.815M |
| March 31, 2017 | -9.597M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-98.00M
Minimum
Mar 2023
654.00M
Maximum
Mar 2022
-3.664M
Average
-57.00M
Median
Jun 2023
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences Inc | 2.219B |
| Catalyst Pharmaceuticals Inc | 55.65M |
| Integra Lifesciences Holdings Corp | 58.75M |
| Palatin Technologies Inc | -10.48M |
| Petros Pharmaceuticals Inc | -2.260M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 28.00M |
| Cash from Financing (Quarterly) | 3.00M |
| Free Cash Flow | -330.00M |
| Free Cash Flow Per Share (Quarterly) | -1.25 |
| Free Cash Flow to Equity (Quarterly) | -94.00M |
| Free Cash Flow to Firm (Quarterly) | -94.00M |
| Free Cash Flow Yield | -29.01% |